CLINICAL_TRIALS
trial_result
· 2012-05-23
Clinical Trial Update: Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia [Phase 1, Phase 2]
Summary
This document notes the completion of a dose-escalation, Phase 1/2 trial of QLT0074 for benign prostatic hyperplasia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: QLT Inc. | Conditions: Benign Prostatic Hyperplasia | Phase 1, Phase 2 | Status: COMPLETED